MedPath

Regina Elena Cancer Institute

🇮🇹Italy
Ownership
Private
Employees
-
Market Cap
-
Website

PRO Survivorship Concerns ITA

Recruiting
Conditions
Psychological Distress
Breast Neoplasm Female
Quality of Life
First Posted Date
2023-10-12
Last Posted Date
2024-03-25
Lead Sponsor
Regina Elena Cancer Institute
Target Recruit Count
280
Registration Number
NCT06080607
Locations
🇮🇹

"Regina Elena" National Cancer Institute, Rome, Italy

🇮🇹

Regina Elena Cancer Institute, Rome, Roma, Italy

GENomic PROfilation for Therapeutic Purposes in SARComas and Molecular Tumor Board (MTB): Retrospective/Prospective Study in Referral Centers

Recruiting
Conditions
Sarcoma
First Posted Date
2023-10-10
Last Posted Date
2023-10-10
Lead Sponsor
Regina Elena Cancer Institute
Target Recruit Count
10
Registration Number
NCT06076070
Locations
🇮🇹

"Regina Elena" National Cancer Institute, Rome, Italy

Versatile Ampification Single-Molecule Detection in Liquid Biopsy

Recruiting
Conditions
Liquid Biopsy
Melanoma (Skin)
Melanoma Stage III
Melanoma Stage IV
First Posted Date
2023-07-11
Last Posted Date
2024-11-27
Lead Sponsor
Regina Elena Cancer Institute
Target Recruit Count
20
Registration Number
NCT05940311
Locations
🇮🇹

"Regina Elena" National Cancer Institute, Rome, Italy

Observational Study of Viral BIOmarkers and microRNAs in Tumors Orofarynx and Occult Tumors Positive for Papilloma Virus

Recruiting
Conditions
Lymph Node Metastasis
High-risk Human Papillomavirus Infection
Liquid Biopsy
Carcinomas of Unknown Primary Site
Occult Tumor of the Head and Neck Area
Squamous Cell Carcinoma of the Oropharynx
Interventions
Diagnostic Test: Study of Viral BIOmarkers and microRNAs in Tumors Orofarynx
First Posted Date
2023-06-26
Last Posted Date
2023-10-10
Lead Sponsor
Regina Elena Cancer Institute
Target Recruit Count
142
Registration Number
NCT05918510
Locations
🇮🇹

"Regina Elena" National Cancer Institute, Rome, Italy

Movement Analysis in Musculoskeletal Oncology: a Pilot Study

Recruiting
Conditions
Motion Analysis in Musculoskeletal Oncology
Interventions
Device: Motion Analysis in Musculoskeletal Oncology
First Posted Date
2023-06-26
Last Posted Date
2024-01-16
Lead Sponsor
Regina Elena Cancer Institute
Target Recruit Count
30
Registration Number
NCT05918549
Locations
🇮🇹

"Regina Elena" National Cancer Institute, Rome, Italy

Orthopedic Oncology Surgery: Navigation, Intraoperative Imaging and Virtual Reality

Recruiting
Conditions
Muscle Neoplasm
Neoplasms
Interventions
Diagnostic Test: evaluate the quality of surgical margins achievable with the use of navigated Intraoperative CT
First Posted Date
2023-06-26
Last Posted Date
2023-06-26
Lead Sponsor
Regina Elena Cancer Institute
Target Recruit Count
45
Registration Number
NCT05918536
Locations
🇮🇹

"Regina Elena" National Cancer Institute, Rome, Italy

Biobanking and New Biomolecular Metrics

Not Applicable
Recruiting
Conditions
Liquid Biopsy
Melanoma (Skin)
First Posted Date
2023-06-15
Last Posted Date
2023-06-15
Lead Sponsor
Regina Elena Cancer Institute
Target Recruit Count
300
Registration Number
NCT05906277
Locations
🇮🇹

IRE, Roma, Italy

Transcriptomics and Epigenetics Analysis in Drug-Resistance of Multiple Myeloma

Recruiting
Conditions
Multiple Myeloma
Interventions
Other: ChIP-seq, NGS, ATAC-seq
First Posted Date
2023-06-05
Last Posted Date
2024-03-22
Lead Sponsor
Regina Elena Cancer Institute
Target Recruit Count
200
Registration Number
NCT05888636
Locations
🇮🇹

Regina elena Cancer Institute, Roma, Italy

🇮🇹

"Regina Elena" National Cancer Institute, Rome, Italy

EXPERIMENTAL STUDY A.R.C.O. (CANCER CAREGIVER REMOTE ASSISTANCE)TELEHEALTH HOME MEDICATION VS/OUTPATIENT MEDICATION OF CENTRAL VENOUS CATHETER PICC (PERIPHERALLY INSERTED CENTRAL VENOUS CATHETER)

Not Applicable
Completed
Conditions
Infections
Interventions
Device: Caregiver operations with medication accessories
Device: Nurse operations with medication accessories
First Posted Date
2023-05-30
Last Posted Date
2023-06-18
Lead Sponsor
Regina Elena Cancer Institute
Target Recruit Count
27
Registration Number
NCT05880420
Locations
🇮🇹

"Regina Elena" National Cancer Institute, Rome, Italy

Inhibition of Che-1/AATF as a New Tool in Multiple Myeloma Treatment

Recruiting
Conditions
Multiple Myeloma
First Posted Date
2023-05-15
Last Posted Date
2023-05-15
Lead Sponsor
Regina Elena Cancer Institute
Target Recruit Count
150
Registration Number
NCT05858203
Locations
🇮🇹

"Regina Elena" National Cancer Institute, Rome, Italy

🇮🇹

Regina elena Cancer Institute, Roma, Italy

© Copyright 2025. All Rights Reserved by MedPath